Co-Diagnostics, Inc. to Present at COVID-19 Virtual Conference Hosted by Maxim Group on May 27, 2020

by Co-Diagnostics | May 27, 2020 | News Release

Salt Lake City, Utah – May 27, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that Company CEO Dwight Egan has been invited to present...

Co-Diagnostics, Inc. COVID-19 Test Successfully Used to Identify Coronavirus in Cancer Tissue

by Co-Diagnostics | May 26, 2020 | News Release

Tissue from presymptomatic patient in Italy was found to contain SARS-CoV-2 using Company’s Logix Smart™ COVID-19 test kit Salt Lake City, Utah – May 26, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented...

Co-Diagnostics, Inc. Releases Prepared Remarks for First Quarter 2020 Conference Call

by Co-Diagnostics | May 14, 2020 | News Release

Salt Lake City, Utah – May 12, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, releases the prepared remarks for the Q1 2020 conference call scheduled...

Co-Diagnostics, Inc. Announces Q1 2020 Results and Provides Mid-Second Quarter Update

by Co-Diagnostics | May 14, 2020 | News Release

Company reports robust sales of COVID-19 tests as Co-Diagnostics generates net profit through middle of second quarter   Salt Lake City, Utah – May 14, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented...

Co-Diagnostics, Inc. Announces Q1 2020 Earnings Release Date and Earnings Call

by Co-Diagnostics | May 12, 2020 | Uncategorized

Salt Lake City, Utah – May 12, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will release its first quarter 2020 earnings on...